BSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹449.00
- Market cap
- ₹4,098 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 21.4×Sector 48.7×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Aarti Drugs Other Announcement
Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.
Aarti Drugs Management Change
Aarti Drugs Ltd announced the retirement of Director Uday M. Patil and the appointment of new directors, including Adhish P. Patil as the Managing Director.
Aarti Drugs Investor Presentation: Key Takeaways
Aarti Drugs reports Q1 FY27 revenue of ₹704 Cr, up 19% YoY. Management focuses on scaling regulated market sales through high-margin formulations and oncology backward integration.
Aarti Drugs Annual General Meeting
Aarti Drugs Limited conducted its 41st Annual General Meeting on September 26, 2026, to consider various ordinary and special business resolutions.
Other board meeting date announcements
All →FCS Software Solutions Board Meeting Date
FCS Software Solutions intimated that its Board will meet on 4 Nov 2026. The agenda includes approval of unaudited H1/Q2 financial results.
EL Forge Board Meeting Date
El Forge Ltd scheduled a board meeting on November 7, 2026, to consider Q1 and H1 FY2027 results. Trading window stays closed until 48 hours post-disclosure.
Diffusion Engineers Board Meeting Date
Diffusion Engineers Ltd scheduled its board meeting for 4 November 2026 to approve Q1 FY27 unaudited financial results. Trading window reopens 48 hours post-declaration.
Veer Energy & Infrastructure Board Meeting Date
Veer Energy & Infrastructure Ltd intimated its Board meeting on 14 Nov 2026 to consider Q1/H1 results. Trading window reopens 17 Nov 2026.
M & B Engineering Board Meeting Date
M&B Engineering schedules a board meeting on 5 Nov 2026 to consider and approve unaudited financial results for Q1 and H1 FY27. No results or financial figures are disclosed in this intimation.
Allcargo Terminals Board Meeting Date
Allcargo Terminals scheduled a board meeting for 4 Nov 2026 to approve Q1/H1 FY27 financial results. The trading window remains closed until 6 Nov 2026.